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Introduction
Hepatocellular carcinoma (HCC) is one of the most prev-
alent malignancies in Japan. Invasion and metastasis of
HCC are frequently observed during the development of
HCCs, and are regulated by matrix metalloproteinases
(MMPs) and tissue inhibitor of metalloproteinases
(TIMPs). We have previously reported the strong expres-
sion of TIMP-1 and TIMP-2, and cellular localization of
the transcripts in HCCs [1]. But the mechanisms of inva-
sion and metastasis of HCCs, and particularly the role of
TIMPs are still unclear. The purpose of this study was to
examine the tissue concentration of the TIMP-1 and to
study the potential involvement of TIMP-1 in the develop-
ment of HCCs.
Methods
Patients and Tissue Preparation
A total of 60 HCC nodules that received curative surgical
resection were studied. The nodules had received no pre-
treatment. Clinical backgrounds of the patients are shown
in Table 1. The tissue was divided into HCC and non-neo-
plastic liver. Tissue samples (~100 mg) of HCC and non-
neoplastic liver were homogenized in 150 microliters of
0.5 M Tris, 1.5 M NaCl, 50 mM CaCl2, 2 mM sodium
azide, pH 7.6. The homogenate was centrifuged at 15000
× g for 15 min at 4 degrees C and the supernatant was
stored at -80 degrees C until analysis.
Assay for tissue TIMP-1 concentration
TIMP-1 concentration in the supernatant of tissue
homogenate of HCC and non-neoplastic liver was meas-
ured by a Enzyme-Linked Immunosorbent Assay system,
using a commercial assay kit (Fuji Chemical Co. Japan),
which contains two kinds of monoclonal antibodies
against bovine TIMP-1.
Statistics
Difference between the tissue TIMP-1 concentration of
HCC and that of non-neoplastic liver was examined by
Student's t test. The Mann-Whitney's U-test was per-
formed to compare the relationship between tissue TIMP-
1 concentration and clinicopathological features.
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Results
Tissue TIMP-1 concentration
The TIMP-1 concentration in HCC was 520 ± 602 (mean
± SD) ng/mg protein, and was significantly (p < 0.0001)
higher than that in the corresponding non-neoplastic liver
(114 ± 212).
Correlation between tissue TIMP-1 concentration and 
pathological features
The TIMP-1 concentration in HCC was examined in the
various conditions of HCC invasion; those include the
differentiation grade, the presence or absence of capsular
formation, the capsular invasion, and the vascular inva-
sion. These results are shown in Table 2. The TIMP-1 con-
centration of HCC in poorly differentiated HCC was
higher than that in well and moderately differentiated
HCC (p < 0.01 and p < 0.02, respectively).
Correlation between tissue TIMP-1 concentration and 
clinical features
The TIMP-1 concentration in HCC was examined in the
various conditions of clinical features, that include the age
of the patients, the underlying liver (liver cirrhosis or
chronic hepatitis), the type of viral infection (hepatitis B
virus or hepatitis C virus), serum alpha fetoprotein (AFP)
levels, and tumor size. The TIMP-1 concentration in liver
cirrhosis was higher than that in chronic hepatitis (p <
0.01).
Discussion
The present study demonstrated that tissue TIMP-1 con-
centration in HCCs was significantly higher than that in
non-neoplastic liver and that the TIMP-1 concentration in
poorly differentiated HCCs was significantly higher than
that of well and moderately differentiated HCCs. We have
previously reported by using in situ hybridization that the
expression of TIMP-1 in HCCs was stronger than that in
non-neoplastic liver [1]. The present study further con-
Table 1: Characteristics of the Patients Investigated in this Study
n
Cases 58
HCC nodules 60
Age 46–75 (median 66)
Sex Male 46
Female 12
Background Chronic hepatitis 42
Liver cirrhosis 16
Viral infection hepatitis B virus (HBV) 14
hepatitis C virus (HCV) 42
HBV and HCV 2
Serum AFP (ng/ml, mean ± SD) 766 ± 2935
Tumor size in diameter (mm, mean ± SD) 31 ± 21
Table 2: TIMP-1 concentration and pathological features of HCCs
TIMP-1 concentration in
Category n HCC NN
Differentiation grade Well 12 177* 55
Moderate 42 254** 63
Poor 6 1020*** 74
Capsular formation present 48 228 63
absent 12 564 51
Capsular invasion present 39 244 72
absent 9 211 45
Vascular invasion present 13 867 63
absent 47 252 57
* vs ***: p < 0.01 ** vs ***: p < 0.02 TIMP-1 concentrations are expressed as median value. NN: non-neoplastic liver.
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firms that TIMP-1 is up-regulated in HCCs not only in the
transcription but also in the translation level. The primary
biological function of TIMPs is the inhibition of MMPs.
When the cancer invades the surrounding non-neoplastic
tissue, MMPs may play a major role to degrade extracellu-
lar matrices. TIMPs play an important role in the regula-
tion of the action of MMPs. But, it has been reported that
tissue TIMP-1 concentration in gastric cancer was associ-
ated with various pathological factors, and patients with
high tissue TIMP-1 concentration had poor prognosis in
comparison to those with low TIMP-1 level [2]. The ele-
vated TIMP-1 level was also associated with poor progno-
sis in lung cancer [3]. It is intriguing that the TIMP-1
concentration in poorly differentiated HCCs was signifi-
cantly higher than that of well and moderately differenti-
ated HCCs. Our previous studies on mRNA level have not
shown the similar results to the present study on the pro-
tein level. Generally, the lower the differentiation grade of
HCCs, the stronger potential of growth, invasion and
metastasis. TIMP-1 has been reported to be a new cell-
growth factor [4] and also an anti-angiogenic factor [5].
These lines of evidence may be associated with the reason
why the TIMP-1 concentration in poorly differentiated
HCCs was high. Further studies on the functional role of
TIMPs in HCCs are needed.
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